F094 Longitudinal analysis of sleep and physical activity in Huntington’s disease – results from the DOMINO-HD study

<h3>Background</h3> Reduced sleep quality and physical activity (PA) are features of Huntington’s Disease (HD).<sup>1 2</sup> Wearable devices offer a method to monitor these potentially modifiable features, and to track disease progression or treatment response. Aim: To examine sleep and PA over time using wearable devices in HD. <h3>Methods</h3> Participants wore a Fitbit Charge 4<sup>3 4</sup> during a 12-month observational study. Clinical measures at baseline and 12-months included the Unified HD Rating Scale total motor score (UHDRS-TMS) and composite UHDRS (cUHDRS). Daily/nightly Fitbit metrics included total sleep time, percentage rapid eye movement (%REM) and deep (%Deep) sleep, REM latency, awakenings, step count and mean heart rate. Baseline and follow-up were defined as the initial and final four weeks. Data were analysed for 64 participants at baseline (32 male; pre-manifest/manifest=15/49; age=51.5±12.4 years; TMS=26.5±19.5; cUHDRS=10.3±4.9), and 55 participants at follow-up (29 male; pre-manifest/manifest=12/43). For each feature, correlations with cUHDRS and UHDRS-TMS were examined at baseline, and the effect of time was examined using paired t-tests. <h3>Results</h3> Significant moderate correlations were observed between cUHDRS and%REM (R=0.26) and REM Latency (R=-0.29), and between UHDRS-TMS and awakenings (R=-0.26). No significant differences in UHDRS-TMS, cUHDRS, or any sleep metric were observed between baseline and follow-up (289.2±74.4 days), however daily step count decreased (p&lt;0.001). <h3>Conclusions</h3> Longitudinal monitoring using a wrist-worn wearable revealed reduced physical activity, with no change in sleep or clinical scores. Sleep features estimated using Fitbit at home were correlated with clinical scores. Longer monitoring periods may reveal new digital biomarkers to monitor clinical progression in HD. <h3>References</h3> Herzog-Krzywoszanska, Krzywoszanski. <i>Frontiers in Psychiatry</i> 2019. McLaren, <i>et al</i>. <i>Neuropsychology</i> 2021. Doheny, <i>et al. J. Clinical Sleep Medicine</i> 2024. Lozano-Garcia, <i>et al. IEEE Transactions Neural Systems Rehab Eng</i>, 2024.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.212
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

F094 Longitudinal analysis of sleep and physical activity in Huntington’s disease – results from the DOMINO-HD study

Emer P. Doheny, Anne Rosser, Monica Busse, Madeleine M. Lowery et al.
Genetic Neurodegenerative Diseases
article

F094 Longitudinal analysis of sleep and physical activity in Huntington’s disease – results from the DOMINO-HD study

Emer P. Doheny, Anne Rosser, Monica Busse, Madeleine M. Lowery, Astri Arnesen, Cheney Drew, Hans H. Jung, Greg Witkowski, Esther Cubo, P R Morrow
article en

Abstract

<h3>Background</h3> Reduced sleep quality and physical activity (PA) are features of Huntington’s Disease (HD).<sup>1 2</sup> Wearable devices offer a method to monitor these potentially modifiable features, and to track disease progression or treatment response. Aim: To examine sleep and PA over time using wearable devices in HD. <h3>Methods</h3> Participants wore a Fitbit Charge 4<sup>3 4</sup> during a 12-month observational study. Clinical measures at baseline and 12-months included the Unified HD Rating Scale total motor score (UHDRS-TMS) and composite UHDRS (cUHDRS). Daily/nightly Fitbit metrics included total sleep time, percentage rapid eye movement (%REM) and deep (%Deep) sleep, REM latency, awakenings, step count and mean heart rate. Baseline and follow-up were defined as the initial and final four weeks. Data were analysed for 64 participants at baseline (32 male; pre-manifest/manifest=15/49; age=51.5±12.4 years; TMS=26.5±19.5; cUHDRS=10.3±4.9), and 55 participants at follow-up (29 male; pre-manifest/manifest=12/43). For each feature, correlations with cUHDRS and UHDRS-TMS were examined at baseline, and the effect of time was examined using paired t-tests. <h3>Results</h3> Significant moderate correlations were observed between cUHDRS and%REM (R=0.26) and REM Latency (R=-0.29), and between UHDRS-TMS and awakenings (R=-0.26). No significant differences in UHDRS-TMS, cUHDRS, or any sleep metric were observed between baseline and follow-up (289.2±74.4 days), however daily step count decreased (p&lt;0.001). <h3>Conclusions</h3> Longitudinal monitoring using a wrist-worn wearable revealed reduced physical activity, with no change in sleep or clinical scores. Sleep features estimated using Fitbit at home were correlated with clinical scores. Longer monitoring periods may reveal new digital biomarkers to monitor clinical progression in HD. <h3>References</h3> Herzog-Krzywoszanska, Krzywoszanski. <i>Frontiers in Psychiatry</i> 2019. McLaren, <i>et al</i>. <i>Neuropsychology</i> 2021. Doheny, <i>et al. J. Clinical Sleep Medicine</i> 2024. Lozano-Garcia, <i>et al. IEEE Transactions Neural Systems Rehab Eng</i>, 2024.

University College Dublin (IE), University Hospital of Zurich (CH), Huntington's Disease Association (GB), Hospital Universitario de Burgos (ES), Institute of Psychiatry and Neurology (PL), Cardiff University (GB)
Openalex Percentile: Top 84%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.